TARDBP and amyotrophic lateral sclerosis: These validation models not only replicate key pathological features like motor neuron death, TDP-43 abnormalities, and glial cell activation but also exhibit a range of ALS-related phenotypes, including muscle atrophy, dyskinesia, and reduced lifespan [70-73].